Filter Results
:
(2,319)
Show Results For
-
All HBS Web
(8,222)
- Faculty Publications (2,319)
Show Results For
-
All HBS Web
(8,222)
- Faculty Publications (2,319)
health →
- November 2001
- Case
Aventis CropScience and StarLink Corn
By: Ray A. Goldberg and James M Beagle
Aventis CropScience responds to the discovery of an unapproved corn variety in food supplies and draws lessons for the company, industry, and governments.
View Details
- October 2001
- Case
TIGR and ILRI: Solving Problems with Genomics
By: Ray A. Goldberg and James M Beagle
Discusses nonprofit institutional leadership applying advances in genetic science to solve health and animal problems in industrial countries and the developing world.
View Details
- September 2001 (Revised January 2002)
- Case
The American Medical Association-Sunbeam Deal (C): Denouement
By: Ashish Nanda and Kimberly A. Haddad
On September 5, 1997, the American Medical Association(AMA) withdrew from a contract with Sunbeam Corporation, the maker of small home appliances. Sunbeam sued the AMA to pay for the damages or to comply with the contract. The fracas led to the dismissal of three top...
View Details
Keywords:
Medical Services;
Appliances;
Lawsuit;
Litigation;
Professionalism;
Contracts;
Corporate Accountability;
Organizations;
Lawsuits and Litigation;
Health Industry;
Health Industry;
United States
Nanda, Ashish, and Kimberly A. Haddad. "The American Medical Association-Sunbeam Deal (C): Denouement." Harvard Business School Case 802-091, September 2001. (Revised January 2002.)
- August 2001 (Revised March 2008)
- Case
Helios Health (A)
By: Regina E. Herzlinger and Alfred Martin
Helios PC system provides personalized drug information to the patients in the doctor's waiting room. It has met with considerable consumer acceptance and a very high return for the drug companies that sponsor it. What price should it charge them for the service?
View Details
Keywords:
Entrepreneurship;
Price;
Health Care and Treatment;
Information Publishing;
Innovation and Invention;
Product Marketing;
Demand and Consumers;
Health Industry;
Health Industry
Herzlinger, Regina E., and Alfred Martin. "Helios Health (A)." Harvard Business School Case 302-022, August 2001. (Revised March 2008.)
- August 2001 (Revised April 2003)
- Case
International Trachoma Initiative
By: Diana Barrett, James E. Austin and Sheila McCarthy
In an effort to combat trachoma, a major eye disease, the Clark Foundation entered into a partnership with Pfizer Pharmaceuticals. After a successful pilot project, a joint initiative was established (the Trachoma initiative) that has as its goal to eradicate the...
View Details
Keywords:
For-Profit Firms;
Joint Ventures;
Globalization;
Mission and Purpose;
Organizational Culture;
Alliances;
Partners and Partnerships;
Non-Governmental Organizations;
Health Industry
Barrett, Diana, James E. Austin, and Sheila McCarthy. "International Trachoma Initiative." Harvard Business School Case 302-009, August 2001. (Revised April 2003.)
- August 2001 (Revised August 2012)
- Case
BestDoctors, Inc.
By: Regina E. Herzlinger and Seth Bokser
Upon learning the news of a critical illness, patients and their families are shocked, saddened, fearful, and angry all at once. And just as soon as they catch their collective breath, they all ask the same question—a question that has the potential to infuse hope into...
View Details
- August 2001 (Revised February 2020)
- Case
Consumer-Driven Health Care: Medtronic's Health Insurance Options
By: Regina E. Herzlinger, John Hurwitch and Seth Bokser
Describes the variety of health insurance plans that this medical device company offers, including a high-deductible, consumer-driven health plan with a health reimbursement account that also enables health care providers to quote their own prices. Asks students to...
View Details
Keywords:
Health Care and Treatment;
Insurance;
Decision Choices and Conditions;
Compensation and Benefits;
Demand and Consumers
Herzlinger, Regina E., John Hurwitch, and Seth Bokser. "Consumer-Driven Health Care: Medtronic's Health Insurance Options." Harvard Business School Case 302-006, August 2001. (Revised February 2020.)
- August 2001
- Case
Scios, Inc.
Scios, filled with distinguished scientists and experienced managers, nevertheless fails to clear the FDA Phase III process for an important biotechnology drug. This case asks the students to analyze the social costs and benefits of the regulatory process.
View Details
- July 2001 (Revised March 2020)
- Case
Medtronic: Patient Management Initiative (A)
By: Regina E. Herzlinger and Mark P. Allyn
Herzlinger, Regina E., and Mark P. Allyn. "Medtronic: Patient Management Initiative (A)." Harvard Business School Case 302-005, July 2001. (Revised March 2020.)
- July 2001 (Revised August 2005)
- Case
Medicines Company, The
It is early 2001 and the Medicines Co. just received FDA approval to market Angiomax, a blood thinner to be used during angioplasties and heart procedures. It is intended to be a better alternative to Heparin, an 80-year-old drug that costs less then $10 per dose. The...
View Details
Keywords:
Business Model;
Change Management;
Decision Choices and Conditions;
Cost Management;
Price;
Product Marketing;
Product Launch;
Product Development;
Risk and Uncertainty;
Health Industry;
Health Industry
Gourville, John T. "Medicines Company, The." Harvard Business School Case 502-006, July 2001. (Revised August 2005.)
- June 2001
- Case
Cerner Corporation (B)
By: D. Quinn Mills and Matt Salloway
Supplements the (A) case.
View Details
Keywords:
Management;
Management Style;
Leadership;
Leadership Style;
Change;
Employees;
Health Industry
Mills, D. Quinn, and Matt Salloway. "Cerner Corporation (B)." Harvard Business School Case 301-137, June 2001.
- June 2001
- Case
Cerner Corporation (A)
By: D. Quinn Mills and Matt Salloway
The CEO thinks people are not working long enough hours. He sends a memo. This series describes the backlash.
View Details
Keywords:
Crisis Management;
Management Style;
Leadership Style;
Nonverbal Communication;
Employees;
Organizational Culture;
Health Industry
Mills, D. Quinn, and Matt Salloway. "Cerner Corporation (A)." Harvard Business School Case 301-136, June 2001.
- June 2001
- Article
Organizational Differences in Rates of Learning: Evidence from the Adoption of Minimally Invasive Cardiac Surgery
By: Gary P. Pisano, Richard Bohmer and Amy C. Edmondson
Pisano, Gary P., Richard Bohmer, and Amy C. Edmondson. "Organizational Differences in Rates of Learning: Evidence from the Adoption of Minimally Invasive Cardiac Surgery." Management Science 47, no. 6 (June 2001): 752.
- March 2001 (Revised April 2001)
- Case
Montefiore Medical Center
By: Robert S. Kaplan and Syeda Noorein Inamdar
A large urban medical center implements the Balanced Scorecard management tool. Elaine Brennan, senior VP of operations, has reorganized a highly functional health care organization into decentralized patient care centers and support units. Having recently endured the...
View Details
Keywords:
Balanced Scorecard;
Health Care and Treatment;
Management Systems;
Organizational Structure;
Corporate Strategy;
Leadership Development;
Growth and Development Strategy;
Financial Reporting;
Budgets and Budgeting;
Cost Accounting;
Corporate Accountability;
Communication;
Health Industry
Kaplan, Robert S., and Syeda Noorein Inamdar. "Montefiore Medical Center." Harvard Business School Case 101-067, March 2001. (Revised April 2001.)
- March/April 2001
- Article
Organizational Learning in Health Care
By: Richard Bohmer and A. Edmondson
Bohmer, Richard, and A. Edmondson. "Organizational Learning in Health Care." Health Forum Journal (March/April 2001), 32–35.
- January 2001
- Case
Merck Global Health Initiatives (A)
By: James E. Austin, Diana Barrett and James Weber
The case series focuses on Merck's drug donation program and then raises new issues facing management about what to do about HIV/AIDS in Africa given the company's development of a new therapy. Describes collaboration among many parties including the Gates Foundation,...
View Details
Keywords:
Programs;
Philanthropy and Charitable Giving;
Health Disorders;
Health Care and Treatment;
Private Sector;
Public Sector;
Alliances;
Problems and Challenges;
Pharmaceutical Industry;
Botswana
Austin, James E., Diana Barrett, and James Weber. "Merck Global Health Initiatives (A)." Harvard Business School Case 301-088, January 2001.
- January 2001
- Case
Merck Global Health Initiatives (B): Botswana
By: James E. Austin, Diana Barrett and James Weber
The case series focuses on Merck's drug donation program and then raises new issues facing management about what to do about HIV/AIDS in Africa given the company's development of a new therapy. Describes collaboration among many parties including the Gates Foundation,...
View Details
Keywords:
Health Disorders;
Health Care and Treatment;
Private Sector;
Public Sector;
Alliances;
Problems and Challenges;
Africa;
Botswana
Austin, James E., Diana Barrett, and James Weber. "Merck Global Health Initiatives (B): Botswana." Harvard Business School Case 301-089, January 2001.
- January 2001 (Revised May 2003)
- Case
Novartis Pharma: The Business Unit Model
By: Srikant M. Datar, Carin-Isabel Knoop and Cate Reavis
In June 2000, Novartis reorganized its pharmaceutical business to form global business units in oncology, transplantation, ophthalmology, and mature products. The remaining primary care products continued to be managed within global functions (e.g., R&D and marketing)....
View Details
Keywords:
Restructuring;
Recruitment;
Product Marketing;
Organizational Structure;
Problems and Challenges;
Health Industry;
Health Industry
Datar, Srikant M., Carin-Isabel Knoop, and Cate Reavis. "Novartis Pharma: The Business Unit Model." Harvard Business School Case 101-030, January 2001. (Revised May 2003.)
- January 2001
- Case
Abgenix and the XenoMouse
By: Robert J. Dolan
Abgenix has a unique method for generating antibodies useful in treating a number of diseases, including cancer. In early 2000, the company's cancer has performed very well in animal testing and is moving to early stage human testing. Abgenix must decide whether to...
View Details
Keywords:
Product Development;
Marketing Strategy;
Health Testing and Trials;
Risk and Uncertainty;
Technological Innovation;
Innovation Strategy;
Science-Based Business;
Biotechnology Industry
Dolan, Robert J. "Abgenix and the XenoMouse." Harvard Business School Case 501-061, January 2001.
- January 2001 (Revised July 2003)
- Case
Pharmacyclics: Financing Research & Development
By: Malcolm P. Baker, Richard S. Ruback and Aldo Sesia
Pharmacyclics (NASDAQ: PCYC), a pharmaceutical company that manufactures products that will improve existing therapeutic treatments for cancer, arteriosclerosis, and retinal disease, was considering a $60 million private placement in February 2000. The company had more...
View Details
Keywords:
Valuation;
Cash Flow;
Financing and Loans;
Business Startups;
Financial Strategy;
Health Industry;
Health Industry;
Health Industry
Baker, Malcolm P., Richard S. Ruback, and Aldo Sesia. "Pharmacyclics: Financing Research & Development." Harvard Business School Case 201-056, January 2001. (Revised July 2003.)